TerrAscend Corp. (TSNDF)
OTCMKTS · Delayed Price · Currency is USD
0.7000
+0.0140 (2.04%)
Oct 31, 2025, 4:00 PM EDT
TerrAscend Market Cap
TerrAscend has a market cap or net worth of $215.97 million as of October 31, 2025. Its market cap has decreased by -37.22% in one year.
Market Cap
215.97M
Enterprise Value
425.20M
Revenue
299.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 25.82M to 215.97M, an increase of 736.56%. That is a compound annual growth rate of 28.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 215.97M | 16.05% |
| Dec 31, 2024 | 186.10M | -61.11% |
| Dec 29, 2023 | 478.56M | 61.26% |
| Dec 30, 2022 | 296.76M | -74.68% |
| Dec 31, 2021 | 1.17B | -24.29% |
| Dec 31, 2020 | 1.55B | 398.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 355.88M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |